D-0002-2020 Class III Terminated
FDA drug recall D-0002-2020 was initiated by Pfizer Inc. on Sep 12, 2019 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020. The recall status is terminated (terminated Apr 10, 2023). Affected quantity: 7,686 100-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 2, 2019
- Initiation Date
- Sep 12, 2019
- Termination Date
- Apr 10, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7,686 100-count bottles
Product description
Zarontin (ethosuximide capsules, USP) 250 mg, 100-count bottle, Rx Onl,y Made in Netherlands Distributed by Parke-Davis Division of Pfizer In NY, NY 10017, NDC 0071-0237-24
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020.
Distribution pattern
Nationwide in the USA
Code information
Lot #3267079, Exp 09/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0002-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026